Pacifichealth Laboratories Stock Return On Equity
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Return On Equity Analysis
PacificHealth Laboratories' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current PacificHealth Laboratories Return On Equity | -0.75 |
Most of PacificHealth Laboratories' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, PacificHealth Laboratories has a Return On Equity of -0.7461. This is 128.26% lower than that of the Personal Products sector and 105.08% lower than that of the Consumer Staples industry. The return on equity for all United States stocks is 140.68% higher than that of the company.
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
PacificHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 571.89 K | ||||
| Shares Outstanding | 20.87 M | ||||
| Price To Earning | (0.34) X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 6.91 M | ||||
| Gross Profit | 2.99 M | ||||
| EBITDA | (861.23 K) | ||||
| Net Income | (486.31 K) | ||||
| Cash And Equivalents | 324.48 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 54.86 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (503.96 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.8 | ||||
| Beta | -275.06 | ||||
| Market Capitalization | 87 | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (20.59 M) | ||||
| Working Capital | 676 K | ||||
| Current Asset | 1.84 M | ||||
| Current Liabilities | 1.17 M | ||||
| Z Score | -11.0 | ||||
| Net Asset | 1.89 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |